Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $452.85 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $180.42 | 1 | $0 (2022) |
| Cheetah Medical, Inc. | $95.00 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $43.60 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $28.33 | 1 | $0 (2024) |
| Baxter Healthcare | $28.15 | 1 | $0 (2023) |
| Insmed, Inc. | $24.39 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.02 | 1 | $0 (2017) |
| Electromed, Inc. | $17.55 | 1 | $0 (2024) |
| Philips Electronics North America Corporation | $16.39 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70.27 | 3 | AstraZeneca Pharmaceuticals LP ($28.33) |
| 2023 | $88.14 | 4 | GlaxoSmithKline, LLC. ($43.60) |
| 2022 | $180.42 | 1 | Amgen Inc. ($180.42) |
| 2017 | $114.02 | 2 | Cheetah Medical, Inc. ($95.00) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Respiratory | ||||||
| 01/09/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: HFCWO | ||||||
| 11/16/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Medical Device | ||||||
| 06/22/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: IMMUNOLOGY | ||||||
| 01/03/2023 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Airway Clearance Device | ||||||
| 06/01/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $180.42 | General |
| Category: Inflammation | ||||||
| 11/01/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2017 | Cheetah Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $95.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 327 | 480 | $202,476 | $40,593 |
| 2022 | 12 | 319 | 443 | $177,566 | $41,228 |
| 2021 | 11 | 287 | 448 | $174,072 | $40,831 |
| 2020 | 13 | 355 | 525 | $176,001 | $41,467 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 42 | 90 | $84,150 | $15,168 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 126 | $54,936 | $11,794 | 21.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 53 | $14,257 | $3,343 | 23.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 33 | $13,365 | $3,131 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $9,656 | $1,821 | 18.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $7,332 | $1,650 | 22.5% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 20 | 23 | $7,452 | $1,597 | 21.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 15 | 18 | $3,618 | $738.27 | 20.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 17 | 18 | $3,492 | $556.39 | 15.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 13 | 18 | $2,106 | $404.64 | 19.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 19 | 19 | $855.00 | $135.94 | 15.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 16 | 16 | $640.00 | $129.04 | 20.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 20 | 20 | $600.00 | $123.63 | 20.6% |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Office | 2023 | 16 | 17 | $17.00 | $1.90 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 154 | $60,676 | $15,306 | 25.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 38 | 75 | $64,275 | $12,669 | 19.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 43 | $13,373 | $3,527 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $10,300 | $2,712 | 26.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $7,224 | $1,895 | 26.2% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 16 | 17 | $5,066 | $1,254 | 24.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 20 | 23 | $4,186 | $1,094 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $3,906 | $901.18 | 23.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 13 | $2,808 | $737.58 | 26.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 20 | 21 | $3,759 | $620.86 | 16.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 20 | 21 | $1,512 | $416.96 | 27.6% |
About Dr. Marc Jacobs, MD
Dr. Marc Jacobs, MD is a Pulmonary Disease healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073620332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Jacobs, MD has received a total of $452.85 in payments from pharmaceutical and medical device companies, with $70.27 received in 2024. These payments were reported across 10 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($452.85).
As a Medicare-enrolled provider, Jacobs has provided services to 1,288 Medicare beneficiaries, totaling 1,896 services with total Medicare billing of $164,119. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Portland, OR
- Active Since 08/24/2006
- Last Updated 11/21/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1073620332
Products in Payments
- TEZSPIRE (Biological) $180.42
- NUCALA (Biological) $43.60
- FASENRA (Biological) $28.33
- Hillrom - Life 2000 Ventilation System (Device) $28.15
- Arikayce (Drug) $24.39
- OFEV (Drug) $19.02
- SMARTVEST (Device) $17.55
- (8874) inCourage (Device) $16.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Portland
Jordan Fein, M.d, M.D
Pulmonary Disease — Payments: $69,409
Granthem Farr, Do, DO
Pulmonary Disease — Payments: $66,353
Melvin Morganroth, Md, MD
Pulmonary Disease — Payments: $23,131
Dr. Bishoy Zakhary, Md, MD
Pulmonary Disease — Payments: $10,967
Rick Balestra, M.d, M.D
Pulmonary Disease — Payments: $9,856
Vikram Sahni, M.d, M.D
Pulmonary Disease — Payments: $4,784